300 PLZID
Pill imprint 300 PLZID has been identified as Zidovudine 300 mg.
Zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure; reduction of perinatal transmission of hiv and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Zidovudine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Zidovudine Images
- Imprint:
-
300
PLZID - Strength:
- 300 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
Advertisement
More Zidovudine resources
- Zidovudine (Wolters Kluwer)
- Zidovudine Capsules (Wolters Kluwer)
- Zidovudine Syrup (Wolters Kluwer)
- zidovudine (Cerner Multum)
- zidovudine injection (Cerner Multum)
- zidovudine (Micromedex) - Includes Dosage Information
- zidovudine Intravenous (Micromedex) - Includes Dosage Information
- Zidovudine (AHFS DI)
- Retrovir Infusion (FDA)
- Zidovudine (FDA)
- Zidovudine Oral Solution (FDA)
- Zidovudine Tablets (FDA)
- Zidovudine (Azidothymidine; AZT; Compound S) (Wolters Kluwer)
Search Again
